Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 13, 10:41
2815.75
-89.75 (-3.09%)
VOLUME 19,881
LIVE
NSE
Dec 13, 10:41
2817.95
-87.7 (-3.02%)
VOLUME 747,342
News on Dr Reddys Laboratories
Select Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Ipca Labs, Lupin top picks in pharma space: Agarwal 

1.05 pm | 21 Dec 2011 |  Source: CNBC-TV18

Ipca Labs and Lupin are top picks in pharma space, says Rajesh Agarwal, Head of Research, Eastern Financiers....

6 stocks likely to see lot of action today 

8.35 am | 07 Dec 2011 |  Source: CNBC-TV18

On CNBC-TV18's show Super Six, market gurus Manas Jaiswal, Technical Analyst, manasjaiswal.com, Vishal Kshatriya, Sr. Derivative and Technical Analyst...

Sun Pharma has target of Rs 553, says Sukhani 

2.33 pm | 05 Dec 2011 |  Source: CNBC-TV18

Sun Pharma has target of Rs 553, says Sudarshan Sukhani, s2analytics.com....

Q2 report card: Pharma sector posts encouraging numbers 

10.32 pm | 02 Dec 2011 |  Source: CNBC-TV18

After a sluggish first quarter, pharma universe reported some encouraging numbers in the second quarter. This is with some support from stable growth ...

Ajanta Pharma has target of Rs 425: PN Vijay 

11.26 am | 28 Nov 2011 |  Source: CNBC-TV18

Ajanta Pharma has target of Rs 425 in the next 12 months, says PN Vijay, Portfolio Manager....

Buy Dr Reddys Labs, Cipla on decline: Sukhani 

7.36 pm | 25 Nov 2011 |  Source: CNBC-TV18

Sudarshan Sukhani, technicaltrends.com is of the view that one can buy Dr Reddys Laboratories, Cipla on decline....

Buy Dr Reddys Lab: Sudarshan Sukhani 

9.11 am | 15 Nov 2011 |  Source: CNBC-TV18

Buy Dr Reddys Laboratories, says Sudarshan Sukhani of technicaltrends.com. ...

Buy Dr Reddys Laboratories; target Rs 1,689: IIFL

3.58 pm | 14 Nov 2011 |  Source: Moneycontrol.com

IIFL is bullish on Dr Reddys Laboratories and has recommended buy rating on the stock with a target price of Rs 1,689 in its November 14, 2011 researc...

Super Six intraday picks for the day 

9.24 am | 02 Nov 2011 |  Source: CNBC-TV18

On CNBC-TV18's new show Super Six, market gurus Hemen Kapadia, CEO of chartpundit.com, Rajesh Jain, EVP Retail Research, Religare Sec and Sanjeev Agar...

Hold Dr Reddys Laboratories; target Rs 1604: Emkay

4.59 pm | 01 Nov 2011 |  Source: Moneycontrol.com

Emkay Global Financial Services has recommended hold rating on Dr Reddys Laboratories with a target of Rs 1604, in its October 25, 2011 research repor...

Buy Dr Reddys Labs; target of Rs 1920: Angel Broking

1.31 pm | 01 Nov 2011 |  Source: Moneycontrol.com

Angel Broking is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 1920 in its October 28, 2011 research repor...

Business from Russia, US markets add to Dr Reddy's coffers 

6.21 pm | 25 Oct 2011 |  Source: CNBC-TV18

G V Prasad, VC & CEO, Dr Reddy's Laboratories tells CNBC-TV18 that North America, Russia and the Pharmaceuticals Services and Active Ingredients (PSAI...

Dr Reddy's Laboratories Q2 net up 7.4% at Rs 308 cr

4.11 pm | 25 Oct 2011 |  Source: CNBC-TV18

Pharmaceutical firm Dr Reddy's Labs has reported better than expected increase of 7.4% in consolidated net profit of Rs 308 crore for the second quart...

Buy Bajaj Auto, Bharti Airtel, Dr Reddys, HUL: Bansal 

2.49 pm | 25 Oct 2011 |  Source: CNBC-Awaaz

Rakesh Bansal for rajeshbansal.com is positive on Bajaj Auto, Bharti Airtel, Dr Reddys and HUL....

DRL Q2 PAT seen down 6% to Rs 270 cr YoY

8.28 am | 25 Oct 2011 |  Source: CNBC-TV18

Dr Reddy's Labs (DRL) is expected to report a profit after tax of Rs 270 crore for the second quarter of FY12, a fall of 6% as compared to Rs 286.8 cr...

Dr Reddys Sept qtr PAT seen at Rs 241 cr: KR Choksey

3.52 pm | 15 Oct 2011 |  Source: Moneycontrol.com

KR Choksey has come out with its earning estimates on Pharma sector for the quarter ended September 2011. According to the research firm, Dr. Reddys S...

Dr Reddys Sept qtr PAT seen up at Rs 295cr: Angel

12.04 pm | 08 Oct 2011 |  Source: Moneycontrol.com

Angel Broking has come out with its earning estimates on pharma sector for the quarter ended September 2011. According to the research firm, Dr Reddys...

Buy Dr Reddys Labs; target of Rs 1720: Firstcall Research

11.37 am | 30 Sep 2011 |  Source: Moneycontrol.com

Firstcall Research is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 1720 in its September 17, 2011 researc...

Buy Dr Reddys Labs; target of Rs 1787: KRChoksey

11.48 am | 27 Sep 2011 |  Source: Moneycontrol.com

KRChoksey is bullish on Dr Reddys Labs and has recommended buy rating on the stock with a target of Rs 1787 in its September 26, 2011 research report....

Dr Reddy's, JB Chem scrap Rs 137cr deal

6.30 pm | 26 Sep 2011 |  Source: PTI

Drug firm Dr Reddy's Laboratories today said its Rs 137.5 crore deal to acquire pharmaceutical prescription portfolio of JB Chemicals & Pharmaceutical...

1 2 3 4 5 6
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.